Transaminases profile in Algerian patients with type 2 diabetes mellitus

Moscatiello, 2007, Diabetes and liver disease: an ominous association, Nutr Metab Cardiovasc Dis, 17, 63, 10.1016/j.numecd.2006.08.004 Jiamjarasrangsi, 2008, Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand, Diabetes Metab, 34, 283, 10.1016/j.diabet.2008.01.009 Jo, 2009, Serum γ-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria, Clinica Chimica Acta, 403, 234, 10.1016/j.cca.2009.03.035 Yuna, 2009, Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans, Atherosclerosis, 205, 533, 10.1016/j.atherosclerosis.2008.12.012 Vosarova, 2002, High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes, Diabetes, 51, 1889, 10.2337/diabetes.51.6.1889 Monamia, 2008, Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study, Metabolism, 57, 387, 10.1016/j.metabol.2007.10.015 Nakanishi, 2003, Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men, J Intern Med, 254, 287, 10.1046/j.1365-2796.2003.01198.x Nakanishi, 2004, Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men, Diabetes Care, 27, 1427, 10.2337/diacare.27.6.1427 Andre, 2005, Hepatic markers and development of type 2 diabetes in middle-aged men and women: a three-year follow-up study. The DESIR study, Diabetes Metab, 31, 542, 10.1016/S1262-3636(07)70229-X Andre, 2006, Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the DESIR cohort, Diabetologia, 49, 2599, 10.1007/s00125-006-0418-x Hanley, 2004, Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study, Diabetes, 53, 2623, 10.2337/diabetes.53.10.2623 Kim, 2005, Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors, Diabet Med, 22, 1134, 10.1111/j.1464-5491.2005.01581.x Lee, 2003, Gamma-glutamyltransferase and diabetes–a 4-year follow-up study, Diabetologia, 46, 359, 10.1007/s00125-003-1036-5 Nannipieri, 2005, Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study, Diabetes Care, 28, 1757, 10.2337/diacare.28.7.1757 Perry, 1998, Prospective study of serum gamma-glutamyltransferase and risk of NIDDM, Diabetes Care, 21, 732, 10.2337/diacare.21.5.732 Sattar, 2004, Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study, Diabetes, 53, 2855, 10.2337/diabetes.53.11.2855 Wannamethee, 2005, Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men, Diabetes Care, 28, 2913, 10.2337/diacare.28.12.2913 Doi, 2007, Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study, Obesity (SilverSpring), 15, 1841, 10.1038/oby.2007.218 Giannini, 2005, Liver enzyme alteration: a guide for clinicians, CMAJ, 172, 367, 10.1503/cmaj.1040752 Salmela, 1984, Liver function tests in diabetic patients, Diabetes Care, 7, 248, 10.2337/diacare.7.3.248 Erbey, 2000, Prevalence of abnormal serum alanine transaminase levels in obese patients and patients with type 2 diabetes, Am J Med, 109, 588, 10.1016/S0002-9343(00)00602-1 Forlani, 2008, Prevalence of elevated liver enzymes in type 2 diabetes mellitus and its association with the metabolic syndrome, J Endocrinol Invest, 1, 146, 10.1007/BF03345581 udi, 2010, Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus, Ann Saudi Med, 30, 25, 10.5144/0256-4947.59369 Idris, 2011, Liver function tests in type 2 Sudanese diabetic patients, Int J Nutr Metab, 3, 17 Schindhelm, 2006, Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease, Diabetes Metab Res Rev, 22, 437, 10.1002/dmrr.666 Angulo, 2002, Non-alcoholic fatty liver disease, N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Kundrotas, 1993, Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors, Dig Dis Sci, 38, 2145, 10.1007/BF01299887 Strauss, 2000, Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents, J Pediatr, 136, 727 Bellentani, 1994, Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study, Hepatology, 20, 1442, 10.1002/hep.1840200611 Clark, 2003, The prevalence and etiology of elevated aminotransferase levels in the United States, Am J Gastroenterol, 98, 960, 10.1111/j.1572-0241.2003.07486.x Trombetta, 2005, Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study, Aliment Pharmacol Ther, 22, S24, 10.1111/j.1365-2036.2005.02590.x West, 2006, Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes, Q J Med, 99, 871, 10.1093/qjmed/hcl116 Meltzer, 1997, Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans, Am J Epidemiol, 146, 565, 10.1093/oxfordjournals.aje.a009315 Hermos, 2008, Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients, Diabetes Res Clin Pract, 80, 153, 10.1016/j.diabres.2007.11.008 Ruhl, 2003, Determinants of the association of overweight with elevated serum aminotransferase activity in the United States, Gastroenterology, 124, 71, 10.1053/gast.2003.50004 Park, 2005, Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents, Am J Clin Nutr, 82, 1046, 10.1093/ajcn/82.5.1046 Marceau, 1999, Liver pathology and the metabolic syndrome X in severe obesity, J Clin Endocrinol Metab, 484, 1513, 10.1210/jc.84.5.1513 Kotronen, 2008, Liver fat is increased in type 2 diabetic patients and underestimated by serum Alanine Aminotransferase compared with equally obese nondiabetic subjects, Diabetes Care, 31, 165, 10.2337/dc07-1463 Ratziu, 2000, Liver fibrosis in overweight patients, Gastroenterology, 118, 1117, 10.1016/S0016-5085(00)70364-7 Hultcrantz, 1986, Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases, Scand J Gastroenterol, 21, 109, 10.3109/00365528609034632 Skelly, 2001, Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology, J Hepatol, 35, 195, 10.1016/S0168-8278(01)00094-0 Daniel, 1999, Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients, Am J Gastroenterol, 94, 3010, 10.1111/j.1572-0241.1999.01451.x Diehl, 1999, Non-alcoholic steatohepatitis, Semin Liver Dis, 19, 221, 10.1055/s-2007-1007111 Powell, 1990, The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114 Bacon, 1994, Non-alcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6 Schindhelm, 2007, Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study, Atherosclerosis, 191, 391, 10.1016/j.atherosclerosis.2006.04.006 Schindhelm, 2005, Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus, Eur J Clin Invest, 35, 369, 10.1111/j.1365-2362.2005.01502.x Brea, 2005, Non-alcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study, Arterioscler Thromb Vasc Biol, 25, 1045, 10.1161/01.ATV.0000160613.57985.18